DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Wynnewood, PA

14 verified pulmonary disease doctors in Wynnewood.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Pennsylvania State Board of Medicine

Dr. Robert Promisloff, DO

Pulmonary Disease

21 yrs NPPES
NPI 1487635587
1001 CITY LINE AVE, WB 113, Wynnewood, PA 19096(610) 896-0280
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Gregory Lenchner, MD

Pulmonary Disease

21 yrs NPPES
NPI 1154302040
1001 CITY LINE AVE, WB113, Wynnewood, PA 19096(610) 896-0280
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,429 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,429

Total received

53

Transactions

13

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$353.14
AstraZeneca Pharmaceuticals LP$305.27
Insmed, Inc.$169.99
Boehringer Ingelheim Pharmaceuticals, Inc.$167.87
Regeneron Healthcare Solutions, Inc.$106.71
Actelion Pharmaceuticals US, Inc.$99.99

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Gregory Lenchner do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Lauren Rome, MD

Pulmonary Disease

20 yrs NPPES
NPI 1972544823
100 E LANCASTER AVE, SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,146 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,146

Total received

43

Transactions

16

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$300.72
Regeneron Healthcare Solutions, Inc.$203.36
Insmed, Inc.$133.62
GlaxoSmithKline, LLC.$78.78
Boehringer Ingelheim Pharmaceuticals, Inc.$75.17
Mylan Specialty L.P.$63.80

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Lauren Rome do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Catherine Kuntz, MD

Pulmonary Disease

20 yrs NPPES
NPI 1669416640
100 E LANCASTER AVE, SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,490 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,490

Total received

56

Transactions

18

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$443.49
Boehringer Ingelheim Pharmaceuticals, Inc.$303.91
Genzyme Corporation$112.00
Mylan Specialty L.P.$109.56
GlaxoSmithKline, LLC.$78.83
Regeneron Healthcare Solutions, Inc.$77.85

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Catherine Kuntz do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Lee Greenspon, MD

Pulmonary Disease

20 yrs NPPES
NPI 1164467122
100 E LANCASTER AVE, SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $11,177 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$11,177

Total received

47

Transactions

15

Paying companies

Top paying companies

Inari Medical, Inc.$10,174
AstraZeneca Pharmaceuticals LP$273.10
GlaxoSmithKline, LLC.$163.29
Boehringer Ingelheim Pharmaceuticals, Inc.$108.16
Insmed, Inc.$68.69
Genzyme Corporation$57.34

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Lee Greenspon do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Susan Gregory, MD

Pulmonary Disease

20 yrs NPPES
NPI 1619913308
100 E LANCASTER AVE, SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registry
CMS Open Payments· $355.39 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$355.39

Total received

16

Transactions

8

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$77.32
AstraZeneca Pharmaceuticals LP$75.89
GlaxoSmithKline, LLC.$59.18
Genentech USA, Inc.$41.19
Insmed, Inc.$34.04
Gilead Sciences, Inc.$25.55

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 70th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Susan Gregory do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Donald Peterson, MD

Pulmonary Disease

20 yrs NPPES
NPI 1689610453
100 E LANCASTER AVE, SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $594.47 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$594.47

Total received

24

Transactions

10

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$267.08
GlaxoSmithKline, LLC.$89.52
Genzyme Corporation$51.07
Insmed, Inc.$34.04
Axsome Therapeutics, Inc.$31.87
Boehringer Ingelheim Pharmaceuticals, Inc.$28.35

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 75th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Donald Peterson do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Thomas Meyer, MD

Pulmonary Disease

20 yrs NPPES
NPI 1700812641
100 E LANCASTER AVE, SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $126,391 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$126,391

Total received

160

Transactions

17

Paying companies

Top paying companies

Intuitive Surgical, Inc.$124,908
AstraZeneca Pharmaceuticals LP$470.60
GlaxoSmithKline, LLC.$234.68
Mylan Specialty L.P.$104.13
Galvanize Therapeutics, Inc$102.79
ANI Pharmaceuticals, Inc.$100.60

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Thomas Meyer do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Howard Lustine, MD

Pulmonary Disease

20 yrs NPPES
NPI 1881625218
100 E LANCASTER AVE, SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Rochelle Goldberg, MD

Pulmonary Disease

20 yrs NPPES
NPI 1649205386
100 E LANCASTER AVE, PULMONOLOGY ASSOCIATES SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $675.85 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$675.85

Total received

36

Transactions

10

Paying companies

Top paying companies

Jazz Pharmaceuticals Inc.$165.59
Harmony Biosciences LLC$165.01
Axsome Therapeutics, Inc.$132.66
Regeneron Healthcare Solutions, Inc.$53.46
IDORSIA PHARMACEUTICALS US INC$39.71
ANI Pharmaceuticals, Inc.$33.74

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Rochelle Goldberg do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Leah Lande, MD

Pulmonary Disease

20 yrs NPPES
NPI 1164457602
100 E LANCASTER AVE, SUITE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $204.25 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$204.25

Total received

10

Transactions

4

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$115.28
Genzyme Corporation$37.50
AbbVie Inc.$29.31
Merck Sharp & Dohme LLC$22.16

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 65th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Leah Lande do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Eliot Friedman, MD

Pulmonary Disease

20 yrs NPPES
NPI 1659434165
100 E LANCASTER AVE STE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,984 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,984

Total received

18

Transactions

12

Paying companies

Top paying companies

E.R. Squibb & Sons, L.L.C.$1,344
Takeda Pharmaceuticals U.S.A., Inc.$1,015
Genentech, Inc.$326.44
AstraZeneca Pharmaceuticals LP$68.13
GlaxoSmithKline, LLC.$48.34
Mallinckrodt Hospital Products Inc.$30.17

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 89th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Eliot Friedman do not imply any wrongdoing. Many are meals, education, or research support.

Dr. William Fineman, MD

Pulmonary Disease

18 yrs NPPES
NPI 1962688564
259 BARWYNNE RD, Wynnewood, PA 19096(610) 649-8495
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Jacqueline Sutter, DO

Pulmonary Disease

18 yrs NPPES
NPI 1417113325
100 E LANCASTER AVE STE 230, Wynnewood, PA 19096(610) 642-3796
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $32,432 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$32,432

Total received

103

Transactions

14

Paying companies

Top paying companies

Regeneron Healthcare Solutions, Inc.$19,945
Boehringer Ingelheim Pharmaceuticals, Inc.$6,521
AstraZeneca Pharmaceuticals LP$3,986
ANI Pharmaceuticals, Inc.$1,353
GlaxoSmithKline, LLC.$142.94
Genzyme Corporation$112.00

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jacqueline Sutter do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Wynnewood, PA — Verified | DoctorsProof | DoctorsProof